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Abstract
Prognosis in pulmonary hypertension is strictly linked to right ventricle failure, which results from uncoupling between right
ventricle function and its afterload. This study sought to describe how to estimate with echocardiography right ventricular wall
tension, its correlation with right ventricle haemodynamics and its prognostic role. A total of 190 patients without overt right
ventricle failure but with suspected pulmonary hypertension on a previous echocardiogram underwent right heart catheterization
and nearly-simultaneous echocardiography. Right ventricular wall tension was estimated according to Laplace’s law as right ven-
tricle length tricuspid regurgitation peak gradient and it was correlated with right ventricle haemodynamic profile; its potential
prognostic impact was tested along with canonical right ventricle function parameters. Right ventricular wall tension correlated
significantly with invasive estimation of right ventricle end-diastolic pressure (R: 0.343, p< 0.001) and with several other haemo-
dynamic variables, such as mean pulmonary artery pressure, pulmonary artery compliance, transpulmonary gradient, pulmonary
vascular resistance, right atrial pressure and right ventricle stroke work index (all p< 0.001). At a mean follow-up of five years and
three months, only right ventricular wall tension was associated to all-cause mortality (p¼ 0.036), while tricuspid annular plane
systolic excursion (p¼ 0.536), right ventricle fractional area change (p¼ 0.383), right ventricle fractional area change (p¼ 0.076),
tricuspid regurgitation peak gradient (p¼ 0.107) and tricuspid annular plane systolic excursion/tricuspid regurgitation peak gradient
(p¼ 0.181) could not. We identified a novel bedside echocardiographic predictor of altered right ventricle haemodynamics, which
is precociously altered in patients without overt right ventricle failure and is associated to all-cause mortality at a long-term follow-
up. Further studies are needed to confirm its role in pulmonary hypertension patients.
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Introduction
Pulmonary hypertension (PH) is a severe disease with a poor
prognosis,1 which may originate from a primary pulmonary
vascular dysfunction or from right ventricle (RV) pressure
overload secondary to left heart disease.2 In both cases, the
natural history of the disease evolves into progressive RV
failure that represents the main determinant of PH
prognosis.3,4
Several studies have focused on the coupling between RV
function and pulmonary artery (PA) resistance, hence
shaping a pathophysiological background that accurately
describes how RV haemodynamics adapt to the pressure
overload that accompanies PH.5–8 According to this
model, RV–PA coupling is mainly defined by Ees/Ea,
where Ees represents end-systolic RV elastance and Ea
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describes PA elastance; Ees is defined as the slope between
the end-systolic pressure versus the end-systolic volume in
pressure–volume loop under different loading status, while
Ea is defined as the ratio between end-systolic pressure and
stroke volume (SV).6–8
PH is characterized by an initial increase of Ea, to which
the RV responds with enhanced inotropism, thus leading to
higher Ees; since both factors increase in a similar fashion,
in this first phase Ees/Ea will remain normal or nearly
normal. Nevertheless, this adaptive mechanism occurs
at the cost of increased right ventricular end-diastolic
pressure (RVEDP), which translates into raised RV wall
tension (RVWT) and altered RV energetics.6,9 While PH
progresses and PA elastance increases, Ea will eventually
reach a critical point that cannot be further tolerated by
the RV; as RVEDP rises beyond this point, Ees/Ea will
then decrease and signs and symptoms of RV failure
will be manifest.10
We investigated RVWT, derived from transthoracic
echocardiography, in comparison with contemporary avail-
able methods estimating RV haemodynamics, and we
assessed whether it can stratify prognosis in a precocious
phase of PH, when canonical echocardiographic parameters
are expected to be normal or nearly normal.
Methods
Study population
The study population of the present work was selected from
the RIGHT1 study,11 a prospective, blinded study designed
to compare the performance of several echocardiographic
indices of pulmonary haemodynamics. RIGHT1 was con-
ducted between July 2011 and November 2013, enrolling
200 patients with a generic indication for right heart cath-
eterization (RHC) referred to the Haemodynamic
Laboratory of the AOU Citta` della Salute e della Scienza
of Turin. Exclusion criteria included ongoing infusion of
inotropes, overt heart failure, known pulmonary stenosis
or ventilatory support.
Haemodynamic assessment
RHC was performed through femoral or jugular access
according to operator’s preference. Right atrial pressure,
RV pressure, PA pressure and pulmonary capillary wedge
pressure were acquired. The zero reference level was always
set at the midthoracic level. Cardiac output was evaluated
using Fick’s method and/or thermodilution. PA compliance
was calculated according to the single element model as SV/
PA pulsatory pressure (namely, systolic–diastolic PA pres-
sure).12 All measurements were made at end-expiration, and
values used in our analysis were a mean of three acquisi-
tions, in case sinus rhythm was present, or five in case of
atrial fibrillation. Physicians performing the RHC were
blinded to the results of the transthoracic echocardiography.
Hemodynamic values were interpreted according to inter-
national consensus.13,14
Echocardiographic assessment
All patients underwent a complete transthoracic echocardi-
ography within 30min prior to RHC; RHC was started
immediately after echocardiography. A Philips IE33
machine (Philips Medical Systems, Andover, MA) with a
S5 probe was used for all 2D and Doppler acquisitions.
All echocardiographic examinations were performed with
a respirometer for the precise timing of respiratory cycles.
Patients were instructed to breathe normally. All morpho-
logic and functional chamber evaluations were made
according to the international guidelines available in
201315,16; multiple indexes of RV diastolic and systolic func-
tion were acquired accordingly. Two operators (C.M. and
E.A.) performed most of the exams. All measurements were
obtained offline using a dedicated software (ComPACS;
MediMatic S.R.L., Genoa, Italy) by an experienced oper-
ator, blinded to the RHC results.
Right ventricular wall tension
RVWT, based on Laplace–Young’s law, was calculated as
follows
RVWT ¼ TRPGRVD3
TRPG represents transtricuspid pressure gradient,
defined as the maximum gradient across the tricuspid
valve, and it was acquired according to international guide-
lines.15,16 Multiple measurements were made from different
echocardiographic windows and the highest peak gradient
recorded was used in the analysis. RVD3 represents end-
diastolic RV length: this index was preferred to other RV
diameters because the systolic motion of the RV occurs
mainly along its length, and therefore the RV motion
vector runs more parallel to RVD3 than to other RV diam-
eters. However, we are aware that this may be an oversim-
plification of the complex RV geometry. RVD3 was
measured in the RV dedicated four-chamber-view, as sug-
gested by current guidelines.15,16 RV wall thickness was not
included in the traditional Laplace equation due to its sig-
nificant inter- and intra-observer variability, which could
harmfully confound the results.17
Follow-up
The participants in this study were retrospectively investi-
gated for all-cause death via a dedicated software used in
our centre (TrakCare, InterSystems Corporation,
Cambridge, MA, USA); when an event could not be
traced this way, a telephonic follow-up was performed.
Follow-up was censored at death occurrence or at last con-
tact with the patient, be it either clinical or by telephone.
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Statistical analysis
Data were presented as mean standard deviation or as
median and interquartile range when appropriate. The para-
metric distribution of variables was analysed using the
Shapiro–Wilk test. Differences between means were exam-
ined using the Student t test or analysis of variance for nor-
mally distributed variables. The results of the Wilcoxon
rank-sum test or the Kruskal–Wallis test were analysed for
non-normally distributed variables. The relationship
between the echocardiographic estimates and RHC values
was tested using Pearson correlation and linear regression.
Fisher’s R-to-Z transformation was used to examine the
statistical significance of the differences between correl-
ations. Kaplan–Meier cumulative survival was calculated.
In order to assess the cut-off value for RVWT, a receiver
operating characteristic (ROC) analysis was performed and
Youden’s index was used. Two-tail p-value< 0.05 was con-
sidered statistically significant. Statistical analysis was con-
ducted using SPSS, version 21.
Results
Study population
Two-hundred patients were enrolled in this study; 10
patients were excluded due to technical issues during cath-
eterization, inconclusive catheterization results or because
echocardiography could not be performed. One-hundred
and ninety patients were included in the baseline data ana-
lysis; 157 (83%) patients underwent RHC for diagnostic
purposes, 27 (14%) for known PH follow-up and 6 (3%)
for cardiac transplantation follow-up. Basic anthropomet-
ric, haemodynamic and echocardiographic characteristics
are summarized in Table 1. Mean age was 61.9 13.7
years; 103 (54%) were male; and 21 (11%) had prior myo-
cardial infarction. One-hundred and twenty-six (66%)
patients were found to have PH at RHC, 37 (19%) of
whom presented with a precapillary form.2 Among the 37
pre-capillary PH patients, 14 (38%) patients were on PH
follow-up and 8 of them (57%) were using PH-specific
therapies; 23 patients (62%) had a novel diagnosis of pre-
capillary PH.
Echocardiographic parameters of RV diastolic function
are summarized in Table 2; except for E/e’, isovolumetric
relaxation time and deceleration time of the E wave, which
were consistent with altered RV diastolic function, mean
values were within normal limits according to guidelines.
RVD3 and TRPG were both available for 159 patients,
therefore RVWT analyses has been performed in this sub-
population.
Haemodynamic comparison
RVWT was associated with invasive assessment of RVEDP,
with a R index equal to 0.343 (R2: 0.117, p< 0.001), as
depicted in Fig. 1. Contrarily, correlation between validated
echocardiographic methods to estimate RVEDP was not
statistically significant, except for tricuspid E wave velocity
(p¼ 0.002), as shown in Table 3. After Fisher’s R-to-Z
transformation, the correlation between RVWT and
RVEDP was significantly higher than the correlation
between canonical parameters and RVEDP (all p< 0.01),
except for tricuspid E wave velocity (p¼ 0.198). RVWT sig-
nificantly correlated with several indexes of RV uncoupling,
such as pulmonary vascular resistance (PVR), PA pulsatory
Table 1. Demographic, haemodynamic and echocardiographic char-
acteristics of the study population (n¼ 190).
Baseline features
Age (years) 61.85 13.72
Male sex 103 (53.9%)
NYHA I–II 144 (75.80%)
COPD 10 (5.26%)
PH 126 (66%)
Precapillary PH 37 (29%)
Prior myocardial infarction 21 (11.06%)
RHC parameters
Cardiac output by thermodilution (l/min) 5.35 1.87
mPAP (mmHg; n¼ 190) 31.21 12.35
PVR (WU; n¼ 184) 2.68 2.22
PAWP (mmHg; n¼ 190) 17.70 7.67
RVSWI (g/m/beat; n¼ 178) 8.27 4.75
Echocardiographic left heart parameters
EF (%; n¼ 190) 50.29 16.21
LVEDD (mm; n¼ 185) 50.46 9.79
LVEDV (ml; n¼ 161) 111.36 79.08
Lateral mitral S’ wave (cm/s; n¼ 184) 7.27 2.66
Mean mitral E/A (n¼ 135) 1.37 1.79
Mean mitral E/E’ (n¼ 169) 13.85 10.94
Left atrial volume index (ml/mq; n¼ 93) 51.95 22.34
Mild or moderate mitral regurgitation 180 (94.8%)
Echocardiographic right heart parameters
RV FAC (%; n¼ 150) 41.43 10.45
TAPSE (mm; n¼ 183) 20.31 5.59
TRPG (mmHg; n¼ 184) 35.17 17.64
TAPSE/TRPG (mm/mmHg; n¼ 183) 0.72 0.41
RVD3 (mm; n¼ 159) 65.32 8.95
Tricuspid S’ wave (cm/s; n¼ 179) 10.70 2.96
Mild or moderate tricuspid regurgitation 176 (92.6%)
Note: Values in brackets indicate the unit of measurement and number of
patients for each variable.
NYHA: New York Heart Association; COPD: chronic obstructive pulmonary
disease; PH: pulmonary hypertension; mPAP: mean pulmonary artery pressure;
PVR: pulmonary vascular resistance; PAWP: pulmonary artery wedge pressure;
RVSWI: right ventricle stroke work index; EF: ejection fraction; LVEDD: left
ventricle end-diastolic diameter; LVEDV: left ventricle end-diastolic volume; RV
FAC: right ventricle fractional area change; TAPSE: tricuspid annulus plane sys-
tolic excursion; TRPG: tricuspid regurgitation peak gradient.
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pressure, PA compliance, right ventricular stroke work
index (RVSWI) and the ratio between cardiac index (CI)
and mean right atrial pressure (mRAP) (all p< 0.001), as
shown in Fig. 2 and Table 4.
RVWT was significantly higher in patients diagnosed
with PH (2747mmHgmm vs 1422mmHgmm,
p< 0.001), as were TRPG (41.37mmHg vs 23.26mmHg,
p< 0.001) and RVD3 (66.95mm vs 62.02mm, p< 0.001).
Moreover, RVWT showed a slightly higher correlation
with mean pulmonary artery pressure than TRPG and
RVD3 alone (R: 0.74, 0.72 and 0.26, respectively, all
p< 0.001).
Follow-up and survival
Among the 190 patients who were included in the study,
31 (16%) were lost at follow-up, and 159 patients were
included in the analysis. Mean follow-up was five years
and three months; death was observed in 47 (30%) patients.
Among the 27 patients (14%) who were enrolled for PH
follow-up, 5 (19%) died at follow-up.
The 159 patients available for analysis were divided into
two groups by the cut-off value of 1945mmHgmm,
defined by low (RVWT< 1945mmHgmm) or high
RVWT (RVWT> 1945mmHgmm), as calculated by
Table 2. Validated echocardiographic parameters for evaluation of
right ventricular diastolic function (n¼ 190).
E (m/s) 0.43 0.157
A (m/s) 0.43 0.130
E/A 0.97 0.42
E DcT (s) 0.75 0.34
IVRT (ms) 84.86 34.25
E’ (cm/s) 9.19 3.45
A’ (cm/s) 12.24 4.08
E’/A’ 0.8267 0.6259
E/E’ 5.17 2.52
Note: Values are expressed as mean standard deviation.
E DcT: E wave deceleration time; IVRT: isovolumetric relaxation time.
Fig. 1. Relationship between right ventricular end-diastolic pressure and right ventricular wall tension (n¼ 159).
RVWT: right ventricular wall tension; RVEDP: right ventricular end-diastolic pressure.
Table 3. Correlation between echocardiographic parameters of
right ventricular diastolic function and right ventricular end-diastolic
pressure.
Characteristics R–R2 p Values
E (m/s) 0.25–0.06 0.002
A (m/s) 0.08–0.01 0.388
E/A 0.08–0.01 0.399
E DcT (s) 0.01–< 0.01 0.921
IVRT (ms) 0.06–< 0.01 0.499
E’ (cm/s) 0.08–< 0.01 0.307
A’ (cm/s) 0.13–0.02 0.131
E’/A’ 0.12–0.02 0.159
E/E’ 0.03–< 0.01 0.714
E DcT: E wave deceleration time; IVRT: isovolumetric relaxation time.
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Youden’s index in conjunction with ROC analysis. Kaplan
Meier analysis for overall survival showed a global p-value
of 0.036 (OR: 1.67; Fig. 2). In patients with high RVWT,
stratifying survival analysis by PH aetiology (pre vs
post-capillary) did not result significant (p¼ 0.801).
Conversely, stratification of the study population by low
or preserved tricuspid annulus plane systolic excursion
(TAPSE), RV fractional area change or RV S’ according
Fig. 2. Relationship between right ventricular wall tension (RVWT) and cardiac index over mean right atrial pressure (CI/mRAP) (top left panel),
pulmonary artery (PA) pulsatory pressure (top right panel), pulmonary vascular resistance (PVR) (middle left panel), pulmonary artery compliance
(middle right panel), right ventricle stroke work index (RVSWI) (bottom left panel) and tricuspid annular plane systolic excursion over tricuspid
regurgitation peak gradient (TAPSE/TRPG) (bottom right panel). The blue dots indicate patients without pulmonary hypertension (PH); the green
dots denote patients with PH.
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to guidelines’ cut-offs was not associated with survival (log-
rank p-values 0.536, 0.383 and 0.076, respectively) (Fig. 3).
TAPSE/TRPG was not significantly able to predict sur-
vival using the proposed cut-off of 0.36mm/mmHg
(p¼ 0.181)18; a similar result was observed by stratifying
our population according to the TRPG cut-off of
30mmHg (p¼ 0.107).
Discussion
PH prognosis strictly depends on the interplay between pul-
monary circulation and the RV. The coupling between RV
afterload, i.e. pulmonary circulation, and RV global func-
tion is defined by the ratio between RV end-systolic ela-
stance and PA elastance (Ees/Ea), as previously described.
During the first phases of PH, the RV maintains a pseudo-
physiological coupling at the cost of altered metabolism and
increased RVEDP, thus leading to raised RVWT while
patients are still asymptomatic and coupling is preserved.6–9
The aim of this study was to identify a novel echocardio-
graphic parameter which could estimate initial RV stress in
a population without evident RV dysfunction and normal
systolic contractility: we found that RVWT was the only
echocardiographic parameter, apart from tricuspid E wave
velocity, which is associated with a raising RVEDP, which is
the first step in the natural history of RV failure. Moreover,
we observed a significant relationship between this new par-
ameter and a large number of invasive indexes of RV mal-
adaptation to afterload (CI/mRAP, RVSWI) and altered
pulmonary elastance (PA compliance, PA pulsatory
pressure).19
To our knowledge, this is the first study aiming to
find an index able to estimate RV wall stress; few
methods have been proposed to estimate left ventricular
wall tension,20 but none had been assessed for the RV
so far.
In our study, an increase in RVWT reflected into a sig-
nificant increase of all-cause mortality: RVWT showed a
significant prognostic impact with a cut-off of
1945mmHgmm, while traditional parameters of systolic
RV function could not significantly predict prognosis.
This might be due to the characteristics of our population,
consisting of patients without PH or at an early/
intermediate phase of the disease, when the RV still
performs normally or near normally, and therefore canon-
ical parameters of impaired systolic function might not
be significantly altered, while the RV silently starts to
strain against growing PVR. We would also like to
stress the fact that TRPG could not significantly stratify
prognosis with a cut-off value of 30mmHg; however, only
26 patients with TRPG< 30mmHg underwent RHC and a
net, albeit non-significant, separation can be seen between
the two curves of TRPG (p¼ 0.107, Fig. 3). This, however,
stresses the concept that RVWT might have a significant
impact on PH prognosis, which might be more meaning-
ful than TRPG alone, denoting an effective and silent RV
derangement.
Several limits must be addressed. First, in the absence
of a ‘gold standard’ method to estimate RVWT, we had
to rely on indirect hemodynamic indexes of early RV dia-
stolic (and systolic) dysfunction, such as RVEDP.
Furthermore, using RVD3 as the only diameter in the
formula for RVWT calculation is an oversimplification
of the complex RV anatomy; nevertheless, as previously
explained, since RV contraction occurs mainly on the lon-
gitudinal axis, RV length, which runs parallel to this axis,
was chosen to find RVWT. Moreover, a significant asso-
ciation was consistently found between the other RV
diameters and RVWT in several sub-analyses not pre-
sented in this paper. Another limitation of the present
study is the inability to trace back the specific cause of
death; however, it may be inferred that an excess of all-
cause mortality in this population could be largely driven
by cardiovascular death due to the relatively high preva-
lence of PH (66%).
Despite its limitations, this method may be the first step
in the research of predictors of early RV stress in a popula-
tion where the diagnosis must be as premature as possible.
We strongly believe that a deeper analysis of RV stress could
have a huge impact in this field of research, be it either with
magnetic resonance imaging or by invasive haemodynamic
assessment, which could plot a pressure/volume loop to
derive Ees/Ea.21 Our method, however, is simple, bed-side
disposable and cheap, and it could identify patients who
may require further analyses and strict follow-up, due to
the fact that the patient’s RV may be facing a subtle, but
risky, increase of wall tension.
Table 4. Correlation between right ventricular wall tension and
invasive haemodynamic parameters of right ventricular function
(n¼ 159).
Characteristics R–R2 p Value
mPAP 0.742–0.550 <0.001
PA pulsatory pressure 0.740–0.547 <0.001
RV differential pressure 0.794–0.630 <0.001
mRAP 0.326–0.106 <0.001
CI/mRAP 0.209–0.044 0.012
RVSWI 0.326–0.106 <0.001
PA compliance 0.449–0.202 <0.001
PVR 0.531–0.282 <0.001
RV basal diameter 0.326–0.106 <0.001
RV medium diameter 0.403–0.162 <0.001
Right atrium area 0.204–0.042 0.013
RV FAC 0.382–0.146 <0.001
RV end-diastolic area 0.347–0.120 <0.001
PA: pulmonary artery; RV: right ventricle; mRAP: mean right atrium pressure;
CI: cardiac index; PVR: pulmonary vascular resistance; RVSWI: right ventricle
stroke work index; RV FAC: right ventricle fractional area change.
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Conclusions
In conclusion, we identified a novel bedside echocardiographic
predictor of altered RV haemodynamics, which is precociously
altered in patients without overt RV failure and is associated
to all-cause mortality at a long-term follow-up. Further studies
are needed to confirm its role in PH patients, primarily with a
prospective and not a retrospective analysis. We strongly hope
that in the near future, new and more precise methods to
identify silent RV failure will be conceived.
Fig. 3. Kaplan–Meier curves describing cumulative survival for all-cause mortality according to right ventricular wall tension (RVWT) (top left
panel), tricuspid annular plane systolic excursion over tricuspid regurgitation peak gradient (TAPSE/TRPG) (top right panel), TRPG (middle left
panel), TAPSE (middle right panel), tricuspid S’ wave (bottom left panel) and right ventricle fractional area change (RV FAC) (bottom right panel).
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